Dr. Susan M. Shafii, MD
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- University of South Florida College of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 369
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: University of South Florida College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
FL license ME104191 · GA license 70910 -
Surgery Physician
GA license 70910
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Morton Plant Hospital Clearwater, FL
- Mease Countryside Hospital Safety Harbor, FL
- Mease Dunedin Hospital Dunedin, FL
Medical groups
- Baycare Medical Group, Inc. (1,547 clinicians)
- Morton Plant Mease Diagnostic Cardiology LLC (28 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 369
- Services billed
- 772
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 134 | 105 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 64 | 61 |
| New patient office or other outpatient visit, 30-44 minutes | 57 | 57 |
| Ultrasound of both sides of head and neck blood flow | 54 | 54 |
| Established patient office or other outpatient visit, 30-39 minutes | 51 | 41 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 50 | 32 |
| Relocation of arm vein with connection to arm artery for hemodialysis | 42 | 40 |
| Established patient office or other outpatient visit, 10-19 minutes | 38 | 35 |
| New patient office or other outpatient visit, 45-59 minutes | 31 | 31 |
| Revision of hemodialysis graft | 27 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Clearwater, FL | 107 |
| Tramadol Hcl Other prescribers in Clearwater, FL | 83 |
| Rosuvastatin Calcium Other prescribers in Clearwater, FL | 51 |
| Atorvastatin Calcium Other prescribers in Clearwater, FL | 32 |
| Cilostazol Other prescribers in Clearwater, FL | 19 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Clearwater, FL | 12 |
| Gabapentin Other prescribers in Clearwater, FL | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 23 payments worth $1,194 in total to this clinician.
| Boston Scientific Corporation | $827 |
|---|---|
| Alnylam Pharmaceuticals Inc. | $103 |
| Shockwave Medical, Inc | $100 |
| Bsn Medical Inc | $44.07 |
| Ethicon US, LLC | $32.68 |
| W. L. Gore & Associates, Inc. | $31.03 |
| Smith+nephew, Inc. | $22.96 |
| Esperion Therapeutics, Inc. | $16.26 |
| Food and Beverage | $1,194 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $6,108 in research payments for these studies, mostly to the institutions running them.
- Roadster 3
Boston Scientific Corporation - Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease
Boston Scientific Corporation · Completed · NCT05365490
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.